[Antibrucellosis lactoglobulin and a study of its therapeutic action under experimental conditions].
Antibrucellosis lactoglobulin obtained by the author had higher specific antibody titres (1 : 81920) than the gamma-globulin batches prepared earlier from the bovine blood serum (1 : 3200). The suggested antibrucellosis lactoglobulin was harmless, of low reactogenicity and produced a definite therapeutic action when administrated to the infected animals. Since lactoglobulin is less expensive than gamma-globulin further work on the improvement of technology of obtaining the former and on the elaboration of the most effective schemes of its use are of expedience.
D000818:Animals; D002002:Brucella / Q000276:immunology*; D002006:Brucellosis / Q000188:drug therapy; D002417:Cattle / Q000276:immunology; D004359:Drug Therapy, Combination; D006168:Guinea Pigs; D006801:Humans; D007273:Injections, Intramuscular; D007782:Lactoglobulins / Q000276:immunology* / Q000627:therapeutic use / Q000633:toxicity; D051379:Mice; D011817:Rabbits; D013307:Streptomycin / Q000627:therapeutic use
D007782:Lactoglobulins; D013307:Streptomycin
Protivobrutselleznyĭ laktoglobulin i izuchenie ego terapevticheskogo deĭstviia v éksperimente